Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| early stage prostate |
|
Clinical Trial Tests Effect of Ultrasound Waves on Early-Stage Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells. Y Q Liu1, E Kyle2, S Patel2, F Housseau3, Prostate cancer chemoprevention agents exhibit selective activity Case Records of the Massachusetts General Hospital from The New England Journal of Medicine -- Case 18-2007 -- A 54-Year-Old Man with Early-Stage Prostate Mitochondrial mutations in early stage prostate cancer and bodily http://health.usnews.com/articles/health/2007/08/23/technologies-tackle-early- Robotic Surgery: Technologies Tackle Early Stage Prostate Cancer If a biopsy has shown that you have early stage prostate cancer, this website is for you. It gives you the facts about your disease, your treatment choices, Prostate Cancer Decision :: Making the Choice : Deciding What to In this report from ECCO 2005, Tomasz Beer, MD, FACP, reviews the latest controversies in the treatment of early prostate cancer. Advances in Early-Stage Prostate Cancer LEF Disease Prevention and Treatment Protocols: Prostate Cancer (Early Stage) - medical information. Prostate Cancer (Early Stage): Online Reference For Health Concerns Robotic surgery and HIFU are innovative, but it isn't clear that they trump conventional treatments. Technologies Tackle Early-Stage Prostate Cancer - US News and Standard treatment for early stage prostate cancer includes surgery, radiation therapy (external beam or brachytherapy, with or without hormone therapy), UpToDate Early stage prostate cancer: Predicting the pathologic Review the rationale for and results of active surveillance as a management/treatment strategy for men with apparent early stage prostate cancer. Active Surveillance for Early Stage Prostate Cancer Develop an outcome nomogram for early stage prostate cancer based on comprehensive molecular analysis of a large series of well-annotated prostate cancer Sloan-Kettering - SPORE in Prostate Cancer: Prediction Tools for Conformal proton therapy for early-stage prostate cancer - long-term results of 1143 patients from a single institution. Authors: Slater J.D.1; Rossi C.J.; IngentaConnect Conformal proton therapy for early-stage prostate Selected Link (Level 1): Treating Early Stage Prostate Cancer Prostate Cancer: Early Stage Treatment. Treatment of prostate cancer needs to be Prostate Cancer Treatment: Early Stage Disease: Beth Israel That seems to be the sentiment of many men diagnosed with early-stage prostate cancer. Choose surgery and risk lifelong incontinence and often total loss of The Alternative Medicine Mentor: Early-Stage Prostate Cancer Often The new study is the first in the U.S. to test HIFU in men with newly-diagnosed, early-stage prostate cancer. The first patient in the clinical trial Treatment Choices for Early-Stage Prostate Cancer - National This booklet describes the treatment choices available to men diagnosed with early-stage prostate cancer. NIH Publication #05-4659. New Test For Curable Early-Stage Prostate Cancer? "A genetic marker such as GSTP1 that occurs mostly in early-stage prostate cancers may improve the way we diagnose cancer in the future and help us to catch Prostate cancer guide - MayoClinic.com Although mitochondrial mutations are less common in prostate adenocarcinoma, they occur early in cancer progression and they can be detected in bodily |
| early stage prostate |
|
aggressive cancer prostate cancer hereditary prostate cancer prostate seed treatment dvd milking mistress prostate |